Clinical Trial Update: Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating dopaminergic therapy in patients with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: I.R.C.C.S. Fondazione Santa Lucia | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED